However, this notion was contradicted by recently published evidence, which supported the positive role of METCAM/MUC18 in the progression of breast cancer cells [23, 24, 27], similar to its role in the progression of melanoma and prostate cancer cells. This evidence concerns the gene MCAM and prostate carcinoma.